In addition, we also analyzed the mutation frequency of the CEP55 gene in different types of tumors, and the results showed that mutation, amplification, and deep deletion were the main types of mutation forms in the top 5 in uterine carcinosarcoma (5.26%), diffuse large B-cell lymphoma (4.17%), prostate adenocarcinoma (2.83%), and bladder urothelial carcinoma (2.43%), respectively. Here, CEP55 is linked to prostate adenocarcinoma.